Awewura Kwara

CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients

Awewura Kwara, Margaret Lartey, Kwamena WC Sagoe et al. · AIDS · 2009 · 126 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

<i>CYP2B6</i> (c.516G→T) and <i>CYP2A6</i> (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV‐infected patients

Awewura Kwara, Margaret Lartey, Kwamena William Coleman Sagoe et al. · British Journal of Clinical Pharmacology · 2009 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10

Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.

Awewura Kwara, Timothy Flanigan, E.J. Carter · PubMed · 2005 · 93 citations

Public Health, Infectious Diseases, Pharmacotherapy +17

Antiretroviral Drug Concentrations and HIV RNA in the Genital Tract of HIV-Infected Women Receiving Long-Term Highly Active Antiretroviral Therapy

Awewura Kwara, Allison DeLong, Nardin Rezk et al. · Clinical Infectious Diseases · 2008 · 83 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Meningitis caused by a serogroup W135 clone of the ET‐37 complex of <i>Neisseria meningitidis</i> in West Africa

Awewura Kwara, Richard A. Adegbola, P. T. Corrah et al. · Tropical Medicine & International Health · 1998 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +12